2021 Global Dermatology Pipeline Database – by Indication, Clinical Trial Stages, Drug Mechanism Classes and Company – ResearchAndMarkets.comDecember 21, 2021
DUBLIN–(BUSINESS WIRE)–The “Dermatology Pipeline Database – 2021” report has been added to ResearchAndMarkets.com’s offering.
This report provides the most up-to-date information on key pipeline products in the global Dermatology market. It covers emerging therapies for Dermatology disorders in active clinical development stages including early and late-stage clinical trials.
Key indications covered in this database include Impetigo, Atopic Dermatitis, Psoriasis, Erythema multiforme, Alopecia Areata, Acne, and Rosacea. The pipeline data is presented in an excel dashboard with filtering options.
The pipeline data presented in this database helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
The database presents pipeline by Dermatology indications. Key indications covered in this database include Impetigo, Atopic Dermatitis, Psoriasis, Erythema multiforme, Alopecia Areata, Acne, and Rosacea.
By Clinical Trial Stages:
The database provides Dermatology pipeline products by clinical trial stages including both early and late-stage development – phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
By Drug Mechanism Classes:
The database provides Dermatology pipeline products by their dominant drug mechanism class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
The database provides Dermatology pipeline products by the company.
For more information about this report visit https://www.researchandmarkets.com/r/se4cpp
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900